Search results

Involving you in the development of NICE guidance.

Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":

Getting involved with NICE as a voluntary and community sector organisation

The standing committees were responsible for the development of our public health guidance.

People can comment on our guidance at specific stages in its development.

Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.

Health inequalities can be experienced by people grouped by a range of different factors.

How to use NICE guidance to reduce health inequalities during and after pregnancy.

This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal

Our forward view highlights the topics we will prioritise in the coming year.

Home What NICE does Our research work HTA Lab...

Past technology appraisal appeals and decisions